Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury.
about
Cell-Based Therapy for SilicosisEfficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic ReviewUpdate on mesenchymal stem cell-based therapy in lupus and sclerodermaMesenchymal stem/stromal cells as a delivery platform in cell and gene therapiesManagement of fibrosis: the mesenchymal stromal cells breakthroughCell-based therapy in lung regenerative medicineModulation of bleomycin-induced lung fibrosis by pegylated hyaluronidase and dopamine receptor antagonist in miceHuman mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trialsMatrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosisUsing Cell-Based Strategies to Break the Link between Bronchopulmonary Dysplasia and the Development of Chronic Lung Disease in Later LifeHyaluronidase recruits mesenchymal-like cells to the lung and ameliorates fibrosisA prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis.Isolation and characterization of a novel strain of mesenchymal stem cells from mouse umbilical cord: potential application in cell-based therapy.New perspectives in human stem cell therapeutic research.Transplantation of Menstrual Blood-Derived Mesenchymal Stem Cells Promotes the Repair of LPS-Induced Acute Lung Injury.Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease.Amnion Epithelial Cells Promote Lung Repair via Lipoxin A4Mesenchymal Stromal Cell Therapy for Chronic Lung Allograft Dysfunction: Results of a First-in-Man Study.Human Wharton's jelly mesenchymal stem cells promote skin wound healing through paracrine signaling.A preliminary evaluation of efficacy and safety of Wharton's jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus.Stem cells and cell therapy approaches in lung biology and diseases.Therapeutic effects of amniotic fluid-derived mesenchymal stromal cells on lung injury in rats with emphysema.Endogenous and exogenous stem cells: a role in lung repair and use in airway tissue engineering and transplantation.Timing of umbilical cord blood derived mesenchymal stem cells transplantation determines therapeutic efficacy in the neonatal hyperoxic lung injury.Anti-inflammatory effects of adult stem cells in sustained lung injury: a comparative study.Bone marrow stromal cells as immunomodulators. A primer for dermatologists.Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavageAmniotic fluid stem cells from EGFP transgenic mice attenuate hyperoxia-induced acute lung injury.Application of human umbilical cord blood-derived mesenchymal stem cells in disease models.Alveolar epithelial cell therapy with human cord blood-derived hematopoietic progenitor cells.Human CD34+ progenitor cells freshly isolated from umbilical cord blood attenuate inflammatory lung injury following LPS challenge.Human Wharton's Jelly Mesenchymal Stem Cells plasticity augments scar-free skin wound healing with hair growth.Mesenchymal stem cells correct inappropriate epithelial-mesenchyme relation in pulmonary fibrosis using stanniocalcin-1.Epithelial interactions and local engraftment of lung-resident mesenchymal stem cellsLung extracellular matrix and fibroblast function.Meeting report of the first conference of the International Placenta Stem Cell Society (IPLASS).The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factorConditioned medium from amniotic mesenchymal tissue cells reduces progression of bleomycin-induced lung fibrosis.Stem cells and regenerative medicine in lung biology and diseases.Preclinical Studies of Mesenchymal Stem Cell (MSC) Administration in Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review and Meta-Analysis.
P2860
Q26749489-DA617A58-CE07-4A01-9D3C-70D60607FC7EQ26773048-6BD0A4DF-6072-483A-A615-A552DB063044Q26777402-69840C20-F606-4CCC-A739-6CEA4432B009Q26799107-1DCFBFA1-3BEE-4C93-ABF5-CA3E7EC81A4FQ26827231-14466776-CF6B-4176-BE5B-169820B5CE1DQ26852285-B163D9D3-BFE4-4EDD-B5DC-118199B91FB4Q27308781-4DCF0897-D21B-4A26-89F4-2E7284CE9218Q28071916-3E127AAF-E9DA-416D-9C3B-392DD3E70D7DQ28386047-5EA039ED-47B0-409A-AD57-FDF99CA2DAD8Q28393759-3E79D445-48B6-49A2-9513-3480CA639777Q30498118-FFA818AD-1FE5-47B3-87A7-998CB56BBD3AQ30541785-9834174A-31CC-465A-AB7C-A22F60C72D2EQ31134041-67341133-0B92-4E1F-AE32-AD4CB46FF4B2Q33466529-3B2F8D75-F6D2-4A4F-9869-29192F2949DEQ33624240-889296E4-0CAC-483F-B46C-24380E277D31Q33642378-6833868F-FD41-4D6E-99ED-8178989B7CA2Q33722569-60FA8D5D-5023-4161-85B1-1D0FD5D3EF54Q33722670-41A023DC-9BE3-405C-A961-425BA547D2A3Q33746416-5C0B4F4F-39B6-4429-A86F-B3B8FD9E4994Q33746422-11B9FFC2-F68E-44AD-90A8-2CEA433F4E45Q34361245-399B6586-312B-4991-84B4-A402932EBD88Q34363534-2F85DC97-3371-4631-9B10-38342151686FQ34419282-C608902B-1099-483B-BA87-F31EA7D5D657Q34562089-69FE582D-6DF7-4FC9-9F07-76108D74463CQ34924313-4957751B-67CA-40C6-A8E4-D0EB63A25EDDQ34961598-66E90CC0-D320-4E67-8CF2-14A9B878656CQ34964361-D4C0CF90-649C-4A35-A2EA-25857AECE905Q34990601-D56B65A9-A880-4231-B6CB-01AE321223EDQ34992268-809F53B3-B5CE-4C02-9D84-6CE9D28E70E9Q35083333-81EF211F-5E51-40CA-A4BB-B895B3EBECA4Q35099703-55579391-EE77-4AA1-92FD-50A83DD4FE63Q35149079-BDA5DF7A-7B44-47BE-9DFC-C227FD57DEE0Q35153085-B05FFD0B-7E7E-4B94-B631-EB6D6AB10440Q35528076-A1CD888B-0871-4CC3-A23D-AFE4FD149B5BQ35604453-2C18EFDA-4638-4C55-9B67-F287F3D5AEA6Q35624272-8F85844A-C699-4131-AFB9-C54FC3BF1F11Q35654823-AE7C405D-31A2-40D8-9DF6-E491EB2081EAQ35755955-EAB3CB63-3761-41FA-96AB-0CED32EBFD0AQ36014064-1EFBC5E8-8F14-4E1E-909F-8A3215ADF9ECQ36046310-FDA5CEFD-BFE3-4C18-A0E5-3C79CF5339DF
P2860
Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human umbilical cord mesenchym ...... bleomycin-induced lung injury.
@en
Human umbilical cord mesenchym ...... bleomycin-induced lung injury.
@nl
type
label
Human umbilical cord mesenchym ...... bleomycin-induced lung injury.
@en
Human umbilical cord mesenchym ...... bleomycin-induced lung injury.
@nl
prefLabel
Human umbilical cord mesenchym ...... bleomycin-induced lung injury.
@en
Human umbilical cord mesenchym ...... bleomycin-induced lung injury.
@nl
P2093
P2860
P1476
Human umbilical cord mesenchym ...... bleomycin-induced lung injury
@en
P2093
Chrishan S Samuel
Daniel Atienza
Jorge Tchongue
Richard Boyd
Sivakami Ilancheran
Ursula Manuelpillai
Yuben Moodley
P2860
P304
P356
10.2353/AJPATH.2009.080629
P407
P577
2009-06-04T00:00:00Z